BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 21653933)

  • 1. Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin.
    Ito S; Shimada Y; Yamaguchi Y; Yasuda M; Yokoi S; Ito S; Nakano M; Ishiko H; Deguchi T
    Sex Transm Infect; 2011 Aug; 87(5):412-4. PubMed ID: 21653933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance.
    Jensen JS; Bradshaw CS; Tabrizi SN; Fairley CK; Hamasuna R
    Clin Infect Dis; 2008 Dec; 47(12):1546-53. PubMed ID: 18990060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of macrolide resistance in Mycoplasma genitalium in France.
    Chrisment D; Charron A; Cazanave C; Pereyre S; Bébéar C
    J Antimicrob Chemother; 2012 Nov; 67(11):2598-601. PubMed ID: 22773740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan.
    Kikuchi M; Ito S; Yasuda M; Tsuchiya T; Hatazaki K; Takanashi M; Ezaki T; Deguchi T
    J Antimicrob Chemother; 2014 Sep; 69(9):2376-82. PubMed ID: 24894419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin 1.5g Over 5 Days Compared to 1g Single Dose in Urethral Mycoplasma genitalium: Impact on Treatment Outcome and Resistance.
    Read TR; Fairley CK; Tabrizi SN; Bissessor M; Vodstrcil L; Chow EP; Grant M; Danielewski J; Garland SM; Hocking JS; Chen MY; Bradshaw CS
    Clin Infect Dis; 2017 Feb; 64(3):250-256. PubMed ID: 28011607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance.
    Couldwell DL; Tagg KA; Jeoffreys NJ; Gilbert GL
    Int J STD AIDS; 2013 Oct; 24(10):822-8. PubMed ID: 24052013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin.
    Guschin A; Ryzhikh P; Rumyantseva T; Gomberg M; Unemo M
    BMC Infect Dis; 2015 Feb; 15():40. PubMed ID: 25645440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex Assay for Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance Using PlexZyme and PlexPrime Technology.
    Tabrizi SN; Tan LY; Walker S; Twin J; Poljak M; Bradshaw CS; Fairley CK; Bissessor M; Mokany E; Todd AV; Garland SM
    PLoS One; 2016; 11(6):e0156740. PubMed ID: 27271704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High levels of macrolide resistance-associated mutations in Mycoplasma genitalium warrant antibiotic susceptibility-guided treatment.
    Nijhuis RH; Severs TT; Van der Vegt DS; Van Zwet AA; Kusters JG
    J Antimicrob Chemother; 2015 Sep; 70(9):2515-8. PubMed ID: 25995292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women.
    Falk L; Enger M; Jensen JS
    J Antimicrob Chemother; 2015 Nov; 70(11):3134-40. PubMed ID: 26283670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men.
    Mena LA; Mroczkowski TF; Nsuami M; Martin DH
    Clin Infect Dis; 2009 Jun; 48(12):1649-54. PubMed ID: 19438399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Macrolide and/or Fluoroquinolone Resistance Genes in
    Ljubin-Sternak S; Meštrović T; Marijan T; Anušić M; Šuto S; Vraneš J
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674404
    [No Abstract]   [Full Text] [Related]  

  • 13. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens.
    Bissessor M; Tabrizi SN; Twin J; Abdo H; Fairley CK; Chen MY; Vodstrcil LA; Jensen JS; Hocking JS; Garland SM; Bradshaw CS
    Clin Infect Dis; 2015 Apr; 60(8):1228-36. PubMed ID: 25537875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis.
    Machalek DA; Tao Y; Shilling H; Jensen JS; Unemo M; Murray G; Chow EPF; Low N; Garland SM; Vodstrcil LA; Fairley CK; Hocking JS; Zhang L; Bradshaw CS
    Lancet Infect Dis; 2020 Nov; 20(11):1302-1314. PubMed ID: 32622378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which azithromycin regimen should be used for treating
    Horner P; Ingle SM; Garrett F; Blee K; Kong F; Muir P; Moi H
    Sex Transm Infect; 2018 Feb; 94(1):14-20. PubMed ID: 28717050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007-2014.
    Muller EE; Mahlangu MP; Lewis DA; Kularatne RS
    BMC Infect Dis; 2019 Feb; 19(1):148. PubMed ID: 30760230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance.
    Shimada Y; Deguchi T; Nakane K; Masue T; Yasuda M; Yokoi S; Ito S; Nakano M; Ito S; Ishiko H
    Int J Antimicrob Agents; 2010 Sep; 36(3):255-8. PubMed ID: 20580532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for the detection of Mycoplasma genitalium by PCR from clinical specimens and subsequent detection of macrolide resistance-mediating mutations in region V of the 23S rRNA gene.
    Jensen JS
    Methods Mol Biol; 2012; 903():129-39. PubMed ID: 22782815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of the prevalence of macrolide and/or fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Japan.
    Deguchi T; Ito S; Yasuda M; Sato Y; Uchida C; Sawamura M; Manda K; Takanashi M; Kiyota H
    J Infect Chemother; 2018 Nov; 24(11):861-867. PubMed ID: 30190106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin.
    Pereyre S; Renaudin H; Charron A; Bébéar C; Bébéar CM
    J Antimicrob Chemother; 2006 Apr; 57(4):753-6. PubMed ID: 16464889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.